Three medical device giants keep raising dividends with steady demand and strong cash flow.

Abbott Laboratories, Medtronic, and Becton Dickinson, three leading medical device companies, have each increased their dividends recently, continuing long streaks of annual raises—54 years for Abbott, 49 for Medtronic, and consistent growth for Becton Dickinson. These companies benefit from steady demand for medical devices like pacemakers and glucose monitors, which remain essential regardless of economic conditions. Their dividends are supported by strong free cash flow and growing earnings, making them attractive for retirees seeking reliable income with moderate yields between 2% and 3.5%. Risks include debt from acquisitions and business restructurings, but overall, these firms offer a fortress-like growth and income stream for dividend investors.

Abbott Laboratories, Medtronic, and Becton Dickinson continue to attract investors with their strong dividend histories, as seen in their current trading on Pluang. As of Sep 29, 2026 20:42 WIB, Abbott trades at USD 100.38 with a 2.5% dividend yield, Medtronic at USD 88.50 offering a 3.22% yield, and Becton Dickinson at USD 182.26 with a 2.28% yield. Despite slight price declines today, these stocks show solid investor interest, especially Abbott with 75% buy orders on Pluang.